Page last updated: 2024-08-26

u 74389f and phenylephrine

u 74389f has been researched along with phenylephrine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davison, CB; Leahy, KP; Loegering, DJ; Richard, CA1
Altavilla, D; Arlotta, M; Campo, GM; Caputi, AP; Quartarone, C; Saitta, A; Sardella, A; Squadrito, F; Squadrito, G; Urna, G1

Other Studies

2 other study(ies) available for u 74389f and phenylephrine

ArticleYear
The antioxidant, U74389, ameliorates the depression of vascular reactivity caused by lipopolysaccharide.
    Life sciences, 1995, Volume: 57, Issue:20

    Topics: Animals; Antioxidants; Aorta, Thoracic; In Vitro Techniques; Lipopolysaccharides; Male; Muscle, Smooth, Vascular; Phenylephrine; Pregnatrienes; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tumor Necrosis Factor-alpha; Vasoconstriction

1995
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
    European journal of pharmacology, 1999, Mar-12, Volume: 369, Issue:1

    Topics: Alanine Transaminase; Animals; Antioxidants; Aorta, Thoracic; Bilirubin; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Endotoxemia; Heart Rate; In Vitro Techniques; Lipopolysaccharides; Liver; Male; Muscle Contraction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Phenylephrine; Pregnatrienes; Rats; Rats, Sprague-Dawley; Survival Rate; Vasoconstrictor Agents

1999